Form 8-K - Current report:
SEC Accession No. 0001005286-25-000072
Filing Date
2025-04-16
Accepted
2025-04-16 16:40:21
Documents
14
Period of Report
2025-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20250411.htm   iXBRL 8-K 26089
2 EX-10.1 aex1012025x04x16amendmentt.htm EX-10.1 4473
  Complete submission text file 0001005286-25-000072.txt   156183

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20250411.xsd EX-101.SCH 1864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20250411_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20250411_pre.xml EX-101.PRE 12591
16 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20250411_htm.xml XML 2718
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 25843269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)